Analyst firms · Wedbush · ARVN

Wedbush ARVN price target and rating history

Arvinas Inc. (ARVN) · Health Care

Wedbush rates Arvinas Inc. (ARVN) Neutral with a $12 price target, as of its latest action on Mar 12, 2025. It has published 3 rating actions on ARVN since May 2022, including 1 upgrade and 2 downgrades.

Current rating
Neutral
Price target
$12
Median target, all firms
Too few
Actions on ARVN
3

Wedbush price target on ARVN

$24$18$12202420252026
Wedbush price target on ARVN, each point a stated target, October 2023 to March 2025.

Every Wedbush rating on ARVN

How other firms rate ARVN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoEqual WeightAug 4, 2026
CitigroupBuy$15Jan 6, 2026

Questions about Wedbush and ARVN

What is Wedbush's price target for ARVN?
Wedbush's latest stated price target for Arvinas Inc. (ARVN) is $12, from its action on Mar 12, 2025.
What is Wedbush's rating on ARVN?
Wedbush rates ARVN Neutral, a neutral rating, as of Mar 12, 2025.
When did Wedbush last change its view on ARVN?
On Mar 12, 2025, Wedbush downgrades to Neutral from Outperform, price target $57 to $12.

More ARVN rating histories

All Wedbush ratingsARVN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.